SEC Form 4 · accession 0001171843-17-001479
Protara Therapeutics, Inc. · TARA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven Keith Burke
Officer — SVP and Chief Medical Officer
Period of report
Mar 10, 2017
Accepted (ET)
Mar 13, 2017 · 5:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001359931
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 10, 2017 | M | 12,287 | $2.38 | A | 37,601 | D | |
| Common Stock | Mar 10, 2017 | M | 57,934 | $1.27 | A | 95,535 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $2.38 | Mar 10, 2017 | M | 12,287 | D | — | Sep 9, 2017 | Common Stock, $0.001 par value | 12,287 | 0 | D |
| Stock Option (Right to Buy)F2 | $1.27 | Mar 10, 2017 | M | 57,934 | D | — | Oct 25, 2021 | Common Stock, $0.001 par value | 57,934 | 0 | D |
Explanation of responses
- F1The option was granted on September 10, 2007. All shares underlying the option have vested.
- F2The option was granted on October 26, 2011. All shares underlying the option have vested.